APA

Eisfeld A., Kohlschmidt J., Mrózek K., Blachly J. S., Nicolet D., Kroll K., Orwick S., Carroll A. J., Stone R. M., de la Chapelle A., Byrd J. C. & Bloomfield C. D. (20180309). Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2. : Leukemia.

Chicago

Eisfeld A-K, Kohlschmidt J, Mrózek K, Blachly J S, Nicolet D, Kroll K, Orwick S, Carroll A J, Stone R M, de la Chapelle A, Byrd J C and Bloomfield C D. 20180309. Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2. : Leukemia.

Harvard

Eisfeld A., Kohlschmidt J., Mrózek K., Blachly J. S., Nicolet D., Kroll K., Orwick S., Carroll A. J., Stone R. M., de la Chapelle A., Byrd J. C. and Bloomfield C. D. (20180309). Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2. : Leukemia.

MLA

Eisfeld A-K, Kohlschmidt J, Mrózek K, Blachly J S, Nicolet D, Kroll K, Orwick S, Carroll A J, Stone R M, de la Chapelle A, Byrd J C and Bloomfield C D. Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2. : Leukemia. 20180309.